Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Lopez, Rebecca ^a   Arumugam, Arunkumar ^a   Joseph, Riya ^a   Monga, Kanika ^a   Boopalan, Thiyagarajan ^a   Agullo, Pamela ^a   Gutierrez, Christina ^a   Nandy, Sushmita ^a   Subramani, Ramadevi ^a   De La Rosa, Jose Manuel ^a   Lakshmanaswamy, Rajkumar ^a  

^a Paul L Foster School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; HUMANS; HYPERGLYCEMIA; IMMUNOBLOTTING; LEPTIN; MCF-7 CELLS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84894218351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079708     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi: 10.3322/caac.20107.
2. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.doi: 10.3322/caac.20138.
3. Cohen DH, LeRoith D (2012) Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer 19: F27-45. doi: 10.1530/ERC-11-0374.
4. Attner B, Landin-Olsson M, Lithman T, Noreen D, Olsson H (2012) Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden. Cancer Causes Control 23: 769-777. doi: 10.1007/s10552-012-9946-5.
5. Maiti B, Kundranda MN, Spiro TP, Daw HA (2010) The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121: 479-483. doi: 10.1007/s10549-009-0591-y.
6. Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86: s823-835.
7. Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, et al. (2010) Metformin: taking away the candy for cancer? Eur J Cancer 46: 2369-2380. doi: 10.1016/j.ejca.2010.06.012.
8. Zeng L, Biernacka KM, Holly JM, Jarrett C, Morrison AA, et al. (2010) Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. Endocr Relat Cancer 17: 539-551. doi: 10.1677/ERC-09-0221.
9. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, et al. (1997) Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 21: 355-359. (Pubitemid 27190186)
10. Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24: 1448-1453. (Pubitemid 33716436)
11. Masur K, Vetter C, Hinz A, Tomas N, Henrich H, et al. (2011) Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation. Br J Cancer 104: 345-352. doi: 10.1038/sj.bjc.6606050.
12. Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, et al. (2002) Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 1592: 107-116.
13. Yamamoto M, Patel NA, Taggart J, Sridhar R, Cooper DR (1999) A shift from normal to high glucose levels stimulates cell proliferation in drug sensitive MCF-7 human breast cancer cells but not in multidrug resistant MCF-7/ADR cells which overproduce PKC-betaII. Int J Cancer 83: 98-106. (Pubitemid 29409484)
14. Olofsson LE, Pierce AA, Xu AW (2009) Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake. Proc Natl Acad Sci U S A 106: 15932-15937. doi: 10.1073/pnas.0904747106.
15. Chen J (2011) Multiple signal pathways in obesity-associated cancer. Obes Rev 12: 1063-1070. doi: 10.1111/j.1467-789X.2011.00917.x.
16. Galgani M, Procaccini C, De Rosa V, Carbone F, Chieffi P, et al. (2010) Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. J Immunol 185: 7474-7479. doi: 10.4049/jimmunol.1001674.
17. McTiernan A, Irwin M, Vongruenigen V (2010) Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 28: 4074-4080. doi: 10.1200/JCO.2010.27.9752.
18. Bosak K (2012) Managing metabolic syndrome in women. Nurse Pract 37: 14-20; quiz 20-11. doi: 10.1097/01.NPR.0000415871.60058.69.
19. Su H, Jiang L, Carter-Su C, Rui L (2012) Glucose enhances leptin signaling through modulation of AMPK activity. PLoS One 7: e31636. doi: 10.1371/journal.pone.0031636.
20. Anderson GL, Neuhouser ML (2012) Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila) 5: 515-521. doi: 10.1158/1940-6207.CAPR-12-0091.
21. Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI, et al. (2012) The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control 23: 1193-1203. doi: 10.1007/s10552-012-9989-7.
22. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, et al. (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26: 1752-1758. (Pubitemid 36929115)
23. Davis AA, Kaklamani VG (2012) Metabolic syndrome and triple-negative breast cancer: a new paradigm. Int J Breast Cancer 2012: 809291. doi: 10.1155/2012/809291.
24. Guerra B, Fuentes T, Delgado-Guerra S, Guadalupe-Grau A, Olmedillas H, et al. (2008) Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS One 3: e3466. doi: 10.1371/journal.pone.0003466.
25. Walsh LA, Damjanovski S (2011) IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-beta1 resulting in epithelial to mesenchymal transition. Cell Commun Signal 9: 10. doi: 10.1186/1478-811X-9-10.
26. Yan D, Avtanski D, Saxena NK, Sharma D (2012) Leptin-induced epithelialmesenchymal transition in breast cancer cells requires beta-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem 287: 8598-8612. doi: 10.1074/jbc.M111.322800.
27. Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, et al. (2008) Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res 68: 9712-9722. doi: 10.1158/0008-5472.CAN-08-1952.
28. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, et al. (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care 30: 561-567. doi: 10.2337/dc06-0922. (Pubitemid 46354334)
29. Villarreal-Garza C, Shaw-Dulin R, Lara-Medina F, Bacon L, Rivera D, et al. (2012) Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients. Exp Diabetes Res 2012: 732027. doi: 10.1155/2012/732027.